Table 1 Summary of clinical findings of epilepsy patients and controls
From: Dysregulation of the (immuno)proteasome pathway in malformations of cortical development
Pathology type | Number of cases | Gender (M/F) | Mean age (years/range) | Localization | Mean duration of epilepsy (years/range) |
|---|---|---|---|---|---|
mMCD | 6 | 5/1 | 21.5 (19–27) | 3 fr/3 t | 17.3 (11–32) |
FCD IIa | 5 | 3/2 | 34.2 (18–45) | 4 fr/1 t | 22.4 (14–26) |
FCD IIb | 6 | 2/4 | 33 (21–45) | 4 fr/2 t | 24 (15–40) |
Cortical tubers (TSC) | 6 | 3/3 | 7.1 (3–16) | 4 fr/2 t | 5.8 (0.8–13) |
Controls/autopsy | 14 | 8/6 | 27.0 (2–48) | 6 fr/8 t | – |